Microplate ELISAs for soluble VCAM-1 and ICAM-1

Annals of Clinical and Laboratory Science

Volumn 35, Issue 3, 2005, Pages 312-317

  Chang, Pi Yueh ^a   Wu, Tsu Lan ^a   Tsao, Kuo Chien ^a   Li, Chia Chi ^a   Sun, Chien Feng ^a   Wu, James T ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ARUP LABORATORIES   (United States)

Author keywords

Adhesion molecules; ELISA; Microtiter plate; sICAM 1; sVCAM 1

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN G ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER RISK; CARDIOVASCULAR DISEASE; CONJUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SHEEP; STANDARD;

ADULT; AGED; BIOLOGICAL ASSAY; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; SEX CHARACTERISTICS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

OVIS ARIES;

EID: 23844438844     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nathan C. Points of control in inflammation. Nature 2002;420:846-852.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
3. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
4. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
5. Takl PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
6. Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993;4:219-229.
7. Syrigos KN, Salgami E, Karayiannakis AJ, Katirtzoglou N, Sekara E, Roussou P. Prognostic significance of soluble adhesion molecules in Hodgkin's disease. Anticancer Res 2004;24:1243-1247.
8. Green M, Filippou A, Sant G, Theoharides TC. Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis. Urology 2004; 63:688-693.
9. Shin HS, Jung CH, Park HD, Lee SS. The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancer. Korean J Intern Med. 2004;19:48-52.
10. Pasicka Z, Kuzdak K, Czyz W, Stepien H, Komorowski J. Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer. Neoplasma. 2004;51:34-37.
11. Perabo F, Sharma S, Gierer R, Wirger A, Fimmers R, Steiner G, Adam M, Schultze-Seemann W. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies. Indian J Cancer 2001;38:1-7.
12. Ho JW, Poon RT, Tong CS, Fan ST. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma. World J Gastroenterol 2004;10:2014-2018.
13. Qiao XM, Wang ZM. Significance of concentration of serum soluble vascular cell adhesion molecule-1 in epithelial ovarian carcinoma. Ai Zheng 2004;23:81-84.
14. Ross R. Atherosclerosis: an inflammatory disease. NEJM 1999;340:115-126.
15. Carlos TM, Harlan JM. Leukocyte-endothelial cell adhesion molecules. Blood 1994;84:2069-2072.
16. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intracellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672-682.
17. Price DT, Loscalzo J: Cellular adhesion molecules and atherogenesis. Am J Med 1999;107:85-97.
18. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
19. Leinonen ES, Hiukka A, Hurt-Camejo E, Wiklund O, Sarna SS, Mattson Hulten L. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes. J Intern Med 2004;256:119-127.
20. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823.
21. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986.
22. Iiyama K, Hajra E, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85:199-207.
23. Wu TL, Chang PY, Li CC, Tsao KC, Sun CF, Wu JT. Microplate ELISA for urine microalbumin: reference values and results in patients with type 2 diabetes and cardiovascular disease. Ann Clin Lab Sci 2005;35:149-154.
24. Asakura H. Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody. Nippon Rinsho 2002; 60:531-538.
25. Brannigan AE, Watson RW, Beddy D, Hurley H, Fitzpatrick JM, O'Connell PR. Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation. Ann Surg 2002;235:507-511.
26. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687-699.
27. Csiszar A, Ungvari Z, Koller A, Edwards JC, Kaley G. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics 2004; 17:21-30.
28. Lane N. A unifying view of ageing and disease: the double-agent theory. J Theor Biol 2003;225:531-540.